|
| 36183283 | Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease. | Int J Hematol | 2023 |
| 37485375 | Circulating cellular clusters are associated with thrombotic complications and clinical outcomes in COVID-19. | iScience | 2023 |
| 37589970 | Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. | JAMA Oncol | 2023 |
| 37794526 | Artificial intelligence in the prediction of venous thromboembolism: A systematic review and pooled analysis. | Eur J Haematol | 2023 |
| 37538494 | Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. | Res Pract Thromb Haemost | 2023 |
| 37767063 | Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices. | Res Pract Thromb Haemost | 2023 |
| 37121622 | "Pulmonary embolism response teams: changing the paradigm in the care for acute pulmonary embolism": reply. | J Thromb Haemost | 2023 |
| 37454464 | DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network. | Thromb Res | 2023 |
| 37316112 | Reduced Stress-Related Neural Network Activity Mediates the Effect of Alcohol on Cardiovascular Risk. | J Am Coll Cardiol | 2023 |
| 37114202 | Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia. | Crit Care Explor | 2023 |
| 37178771 | Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study. | J Thromb Haemost | 2023 |
| 37274174 | Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias. | Res Pract Thromb Haemost | 2023 |
| 36972785 | Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee. | J Thromb Haemost | 2023 |
| 37367089 | Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms. | Hematol Rep | 2023 |
| 37266947 | Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial. | JAMA | 2023 |
| 36995647 | Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network. | J Thromb Thrombolysis | 2023 |
| 36936238 | Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis. | Front Med (Lausanne) | 2023 |
| 36803697 | Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus Panel. | Am J Med | 2023 |
| 36868268 | Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study. | Semin Thromb Hemost | 2023 |
| 36863565 | Outcomes of venous thromboembolism care: future directions. | J Thromb Haemost | 2023 |
| 36757644 | DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network. | J Thromb Thrombolysis | 2023 |
| 36384716 | Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation. | J Cardiol | 2023 |
| 35202841 | Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. | Contemp Clin Trials | 2022 |
| 35545171 | NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022. | J Natl Compr Canc Netw | 2022 |
| 35702588 | Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment. | Res Pract Thromb Haemost | 2022 |
| 35537232 | Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. | Thromb Res | 2022 |
| 35895858 | Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism. | J Thromb Haemost | 2022 |
| 36055334 | Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. | Lancet Haematol | 2022 |
| 35979196 | Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. | Res Pract Thromb Haemost | 2022 |
| 33848094 | Presentation, Management and Outcomes of Pediatric Pulmonary Embolus: A Retrospective Review. | Pediatr Emerg Care | 2022 |
| 34954228 | Interhospital Transfer for the Management of Acute Pulmonary Embolism. | Am J Med | 2022 |
| 35224417 | COVID-19 and venous thromboembolism: A narrative review. | Res Pract Thromb Haemost | 2022 |
| 35187516 | Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. | Lancet Healthy Longev | 2022 |
| 32795617 | Deep vein thrombosis protocol optimization to minimize healthcare worker exposure in coronavirus disease-2019. | J Vasc Surg Venous Lymphat Disord | 2021 |
| 33714541 | Qualitative and quantitative DECT pulmonary angiography in COVID-19 pneumonia and pulmonary embolism. | Clin Radiol | 2021 |
| 33875503 | Case of right ventricular and aortic thrombi in a patient with severe COVID-19. | BMJ Case Rep | 2021 |
| 33694139 | Venous Thromboembolism: Genetics and Thrombophilias. | Semin Respir Crit Care Med | 2021 |
| 33932247 | Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center. | Oncologist | 2021 |
| 33856099 | Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. | Oncologist | 2021 |
| 33746047 | Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. | Ann Oncol | 2021 |
| 34950930 | A clinical decision framework to guide the outpatient treatment of emergency department patients diagnosed with acute pulmonary embolism or deep vein thrombosis: Results from a multidisciplinary consensus panel. | J Am Coll Emerg Physicians Open | 2021 |
| 34470540 | Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment. | Postgrad Med | 2021 |
| 34514421 | Comparison of Published Guidelines for the Diagnosis and the Management of Vaccine-Induced Immune Thrombotic Thrombocytopenia. | Crit Care Explor | 2021 |
| 34741012 | Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients. | Blood Cancer J | 2021 |
| 34273391 | Interhospital Transfer of Patients With Acute Pulmonary Embolism: Challenges and Opportunities. | Chest | 2021 |
| 34260813 | The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. | J Thromb Haemost | 2021 |
| 34357393 | Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations. | JAMA Netw Open | 2021 |
| 33400098 | Evaluation of direct thrombin inhibitors during a critical heparin shortage. | J Thromb Thrombolysis | 2021 |
| 33026569 | Filter clotting with continuous renal replacement therapy in COVID-19. | J Thromb Thrombolysis | 2021 |
| 33274815 | Prediction and Prevention of Cancer-Associated Thromboembolism. | Oncologist | 2021 |